197 related articles for article (PubMed ID: 33049037)
21. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
22. F221Y mutation in hepatitis B virus reverse transcriptase is associated with hepatocellular carcinoma prognosis following liver resection.
Li H; Jia J; Wang M; Wang H; Gu X; Fang M; Gao C
Mol Med Rep; 2017 May; 15(5):3292-3300. PubMed ID: 28339094
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
[TBL] [Abstract][Full Text] [Related]
24. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.
Yeung P; Wong DK; Lai CL; Fung J; Seto WK; Yuen MF
J Infect Dis; 2011 Mar; 203(5):646-54. PubMed ID: 21227916
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
Chavalit T; Nimsamer P; Sirivassanametha K; Anuntakarun S; Saengchoowong S; Tangkijvanich P; Payungporn S
Microrna; 2020; 9(3):232-239. PubMed ID: 31686644
[TBL] [Abstract][Full Text] [Related]
26. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
[TBL] [Abstract][Full Text] [Related]
27. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
28. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
29. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
31. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
Wong DK; Huang FY; Lai CL; Poon RT; Seto WK; Fung J; Hung IF; Yuen MF
Hepatology; 2011 Sep; 54(3):829-36. PubMed ID: 21809355
[TBL] [Abstract][Full Text] [Related]
32. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.
Yan SY; Fan JG; Qio L
Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954
[TBL] [Abstract][Full Text] [Related]
34. Conservation and variability of hepatitis B core at different chronic hepatitis stages.
Yll M; Cortese MF; Guerrero-Murillo M; Orriols G; Gregori J; Casillas R; González C; Sopena S; Godoy C; Vila M; Tabernero D; Quer J; Rando A; Lopez-Martinez R; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
World J Gastroenterol; 2020 May; 26(20):2584-2598. PubMed ID: 32523313
[TBL] [Abstract][Full Text] [Related]
35. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
36. The dynamic variation position and predominant quasispecies of hepatitis B virus: Novel predictors of early hepatocarcinoma.
Zhang C; An S; Lv R; Li K; Liu H; Li J; Tang Y; Cai Z; Huang T; Long L; Deng W
Virus Res; 2024 Mar; 341():199317. PubMed ID: 38242020
[TBL] [Abstract][Full Text] [Related]
37. Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection.
Godoy C; Tabernero D; Sopena S; Gregori J; Cortese MF; González C; Casillas R; Yll M; Rando A; López-Martínez R; Quer J; González-Aseguinolaza G; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
World J Gastroenterol; 2019 Apr; 25(13):1566-1579. PubMed ID: 30983817
[TBL] [Abstract][Full Text] [Related]
38. A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients.
Teng CF; Huang HY; Li TC; Shyu WC; Wu HC; Lin CY; Su IJ; Jeng LB
Sci Rep; 2018 Oct; 8(1):14816. PubMed ID: 30287845
[TBL] [Abstract][Full Text] [Related]
39. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
40. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
